Investment Summary

GIMV and Andera Partners Invest In Complix

On June 26, 2013, private equity firms GIMV and Andera Partners invested in life science company Complix

Investment Highlights
  • This is GIMV’s 11th and Andera Partners’ 6th transaction in the Life Science sector.
  • This is GIMV’s 28th and Andera Partners’ 2nd transaction in Belgium.

Investment Summary

Date 2013-06-26
Target Complix
Sector Life Science
Investor(s) GIMV
Andera Partners
Deal Type Venture

Target

Complix

Ghent, Belgium
Complix is focused on the discovery and development of alpha bodies, a novel class of biopharmaceuticals that, due to their unique structural and functional properties, are particularly suited to address disease targets that are difficult to reach with antibodies or other types of therapeutic protein scaffolds. Complix was founded in 2008 and is based in Ghent, Belguim.

Search 215,130 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 2

Investor

GIMV

Antwerp, Belgium

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1980
PE ASSETS 2.0B EUR
Size Large
Type Sector Agnostic
DESCRIPTION

GIMV is a Belgium based public investment company focused on private equity and venture capital investments in tech-based businesses. GIMV's private equity practice operates through its Corporate Investment unit and targets management buyouts, buy-ins, and growth capital financings of companies with annual sales between EUR15 and EUR150 million. For buyout opportunities GIMV generally takes a majority stake in businesses and for growth capital needs, GIMV takes a minority position. GIMV does not invest in publicly held companies or turnaround situations. GIMV's geographic focus is within Belgium, Netherlands, Germany, and France. GIMV also invests in Russia through Eagle Capital Partners, a partnership with KBC Private Equity. GIMV was formed in 1980 and is headquartered in Antwerp with additional offices in The Hague, Frankfurt, Munich, and Paris.


DEAL STATS #
Overall 81 of 170
Sector: Life Science M&A 11 of 24
Type: Venture M&A Deals 25 of 39
Country: Belgium M&A 28 of 50
Year: 2013 M&A 7 of 10
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-06-20 Luciad NV

Leuven, Belgium

Luciad NV is a provider of software solutions for building state-of-the-art Situational Awareness systems. Luciad’s visualisation technologies support live connections to dynamic sensor feeds in a 3D environment. The result is a 5D digital reality – real-time, rapid fusion of multi-source content and the ability to perform analytics on-the-fly. Luciad is an international high-tech software company with offices located in Leuven (Belgium), Reston, VA (U.S.A.), Ankara (Turkey), and Paris (France).

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-06-28 Prosensa

Leiden, Netherlands

Prosensa is an operator of a biotechnology company that uses a unique and revolutionary licensed technology platform that makes use of so-called exon skipping for correcting mutated RNA. Prosensa company primarily targets Duchenne Muscular Dystrophy (DMD) disorder, against which it has already developed two products that are currently in clinical phase I / II. Prosensa was founded in 2002 and is based in Leiden, Netherlands.

Sell -
Investor

Andera Partners

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 2001
PE ASSETS 3.7B EUR
Size Large
Type Sector Agnostic
DESCRIPTION

Andera Partners is a private investment firm focused on several strategies. The Firm invests in life science opportunities through its BioDiscovery group. The Firm invests in Western European small to mid-sized companies (€30 to €300 million of revenue) through its Winch Capital group. Andera invests in small to mid-sized French companies (€10 to €100 million of revenue) through its Cabestan Capital team. Andera invests in €5 to €45 million of mezzanine capital to support small to mid-sized French companies. Andera Partners was established in 2001 and is headquartered in Paris.


DEAL STATS #
Overall 29 of 123
Sector: Life Science M&A 6 of 27
Type: Venture M&A Deals 4 of 28
Country: Belgium M&A 2 of 9
Year: 2013 M&A 6 of 7
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-06-25 MDxHealth

Herstal, Belgium

MDxHealth is a molecular diagnostics company that develops and commercializes advanced tests for cancer assessment and the personalized treatment of patients. MDxHealth was founded in 2003 and is based in Herstal, Belgium.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-12-03 Star s service SA

Epinay Sur Seine, France

Star's service SA is a provider of urban logistics. Star's service provides parcel delivery and food shopping for retail, distribution of the spare part to automotive, Food logistics partner to gourmet and logistics partner of health actors. Star's service was founded in 1987 and is based in Epinay-Sur-Seine, France.

Buy -